
Fjalar Kristjansson
About Fjalar Kristjansson
Data last updated:
Fjalar Kristjansson is a Director at Alvogen Pharma (India) Private Limited (since 2010) and Director at Norwich Clinical Services Private Limited (since 2010). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Alvogen Pharma (India) Private Limited at ₹51.32 Cr (FY 2025). Earlier, Fjalar Kristjansson was a Director at Lotus Labs Private Limited (2005–2010) and Director at Lotus Clinical Research Academy Private Limited (from 2007).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Apr 2010 | 2010 | ₹51.32 Cr (FY 2025) | Active | |
| Director | 01 Feb 2010 | 2009 | ₹51.26 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Mar 2005 | 1999 | ₹54.98 Cr (FY 2025) | Active | |
| Director | 15 Jan 2007 | 2006 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Fjalar Kristjansson
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditya Nagaraj Bellur | 07231827 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
| Divya Chandu Patel | 03132296 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Nominee Director |
| Saral Thangam | 01507119 | Alvogen Pharma (India) Private Limited , Norwich Clinical Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Fjalar Kristjansson
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fjalar Kristjansson
Fjalar Kristjansson currently holds 2 directorships: Alvogen Pharma (India) Private Limited (Director, since 13 Apr 2010, revenue ₹51.32 Cr (FY 2025)); Norwich Clinical Services Private Limited (Director, since 01 Feb 2010, revenue ₹51.26 Cr (FY 2025)).
Fjalar Kristjansson was first appointed on 18 Mar 2005 as Director at Lotus Labs Private Limited. The most recent appointment on record is 13 Apr 2010 at Alvogen Pharma (India) Private Limited.
The 2 current companies of Fjalar Kristjansson that report revenue have a combined latest revenue of ₹103 Cr: Alvogen Pharma (India) Private Limited ₹51.32 Cr (FY 2025); Norwich Clinical Services Private Limited ₹51.26 Cr (FY 2025).
Fjalar Kristjansson held 2 earlier board appointments: Lotus Labs Private Limited (Director, 18 Mar 2005 to 02 Feb 2010); Lotus Clinical Research Academy Private Limited (Director, from 15 Jan 2007).
The current boards of Fjalar Kristjansson's companies include Aditya Nagaraj Bellur (Alvogen Pharma (India) Private Limited), Divya Chandu Patel (Alvogen Pharma (India) Private Limited), Saral Thangam (Alvogen Pharma (India) Private Limited).